A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
Status:
RECRUITING
Trial end date:
2029-03-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, multicenter trial of cadonilimab (AK104) with adriamycin in patients with first-line advanced soft tissue sarcoma. the primary objective is to evaluate objective response rate of cadonilimab with adriamycin.
Phase:
PHASE2
Details
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators:
First Affiliated Hospital of Guangxi Medical University Second Xiangya Hospital of Central South University Sun Yat-sen University The Affiliated Hospital Of Guizhou Medical University Xiangya Hospital of Central South University Yunnan Cancer Hospital